How has been the historical performance of Cell Point?

Answer:The historical performance of Cell Point shows a steady increase in net sales over the years, reaching 324.71 Cr in March 2025, up from 321.23 Cr in March 2024, and significantly higher than 295.67 Cr in March 2023. The total operating income mirrored this trend, with a rise to 324.71 Cr in March 2025 from 321.23 Cr in the previous year. However, the operating profit (PBDIT) has seen fluctuations, peaking at 19.34 Cr in March 2023 before declining to 8.88 Cr in March 2025. Profit before tax also experienced a decline, with 2.81 Cr reported in March 2025 compared to 9.87 Cr in March 2023. Profit after tax followed a similar pattern, increasing to 2.26 Cr in March 2025 from 1.69 Cr in March 2024 but down from 6.73 Cr in March 2023.

In terms of assets and liabilities, total assets grew to 137.69 Cr in March 2025 from 133.10 Cr in March 2024, with total liabilities also increasing to 137.69 Cr from 133.10 Cr. The company's cash flow from operating activities was notably negative in March 2024 at -7.00 Cr, but improved to 0.00 Cr in March 2025. The net cash outflow for March 2025 was -5.00 Cr, a decline from a net inflow of 1.00 Cr in March 2024. Overall, while Cell Point has shown growth in sales and total assets, profitability metrics have fluctuated, indicating challenges in maintaining profit levels in recent periods.

Breakdown:
Cell Point's net sales have consistently increased, reaching 324.71 Cr in March 2025, up from 321.23 Cr in March 2024, and significantly higher than previous years. The total operating income followed suit, reflecting the same growth trajectory. However, operating profit (PBDIT) peaked at 19.34 Cr in March 2023 and has since declined to 8.88 Cr in March 2025, indicating volatility in profitability. Profit before tax also decreased to 2.81 Cr in March 2025 from a higher 9.87 Cr in March 2023, while profit after tax showed a slight increase to 2.26 Cr in March 2025 from 1.69 Cr in the prior year, but was down from 6.73 Cr in March 2023. On the balance sheet, total assets rose to 137.69 Cr in March 2025, with total liabilities matching this figure, reflecting a stable financial position despite the challenges in profitability. Cash flow from operating activities improved to 0.00 Cr in March 2025 after a negative performance in the previous year, though the net cash outflow indicates ongoing liquidity challenges.